
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SNY | NASDAQ | USD | Real-time | |
SANp | BATS Europe | EUR | Delayed | |
0O59 | London | EUR | Real-time | |
SNYN | Mexico | MXN | Delayed | |
SANF | Milan | EUR | Real-time | |
SASY | Frankfurt | EUR | Delayed | |
SASY | Xetra | EUR | Delayed | |
SASY | TradeGate | EUR | Delayed | |
SASY | Paris | EUR | Real-time |
Investors are bracing for billions of dollars in losses due to lawsuits filed over the heartburn drug Zantac.
By Natalie Grover and Danilo Masoni LONDON (Reuters) -Shares in GSK, Sanofi (EPA:SASY) and Haleon fell sharply on Thursday, following declines earlier this week, amid growing investor concerns about...
By Natalie Grover LONDON (Reuters) - Shares in GSK, Sanofi (EPA:SASY), Haleon and Pfizer (NYSE:PFE) began to recover on Friday after the companies said that nothing material had changed regarding...
By Sam Boughedda Shares of Sanofi (NASDAQ:SNY) were upgraded to Hold from Sell with an unchanged EUR90 price target by a Deutsche Bank analyst on Friday. Sanofi shares have tumbled in recent days...
For many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga.
By Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) rose on Friday, paring back some heavy recent losses, as the British pharmaceutical giant responded to a bout of speculation around...
LONDON (Reuters) – Shares in GSK, Sanofi
Sanofi was upgraded to hold from sell at Deutsche Bank, after the heavy selling over the previous two days on worries about Zantac heartburn medication litigation. The first trial is set to begin on...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review